 |
PDBsum entry 2fme
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Inhibitors of human mitotic kinesin eg5: characterization of the 4-Phenyl-Tetrahydroisoquinoline lead series.
|
 |
|
Authors
|
 |
C.M.Tarby,
R.F.Kaltenbach,
T.Huynh,
A.Pudzianowski,
H.Shen,
M.Ortega-Nanos,
S.Sheriff,
J.A.Newitt,
P.A.Mcdonnell,
N.Burford,
C.R.Fairchild,
W.Vaccaro,
Z.Chen,
R.M.Borzilleri,
J.Naglich,
L.J.Lombardo,
M.Gottardis,
G.L.Trainor,
D.L.Roussell.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2006,
16,
2095-2100.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
In a high-throughput screening effort, a series of tetrahydroisoquinolines was
identified as modest inhibitors of human Eg5. A medicinal chemistry optimization
effort led to the identification of
R-4-(3-hydroxyphenyl)-N,N-7,8-tetramethyl-3,4-dihydroisoquinoline-2(1H)-carboxamide
(32a) as a potent inhibitor of human Eg5 (ATPase IC50 104 nM) with good
anti-proliferative activity in A2780 cells (IC50 234 nM).
|
 |
|
|
|
|
 |